Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 80

Gait Adaptation Training for people with MS

Official title: Integrative Training Approach for Inducing Neuroplasticity in Multiple Sclerosis

Run by Rutgers, The State University of New Jersey · NCT07660601 · Data updated 2026-11-12

This pilot program tests a gait adaptation training approach to see if it helps improve mobility and thinking skills in adults with multiple sclerosis.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorRutgers, The State University of New Jersey
Academic / other
Locations1 site (Newark, New Jersey)
StatusRecruiting
StartedJanuary 31, 2025
Main results expectedMay 20, 2028
Study endsJuly 20, 2028
Registry record updatedJune 22, 2026
Trial IDNCT07660601 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 80 with a clinically definite MS diagnosis who can follow instructions in English and have adequate vision.

Probably not a fit

Patients with ongoing relapse, recent steroid treatment, or other neurological conditions affecting cognition or balance may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early-phase study investigates whether a gait adaptation training program can alter brain-to-muscle and brain-to-brain connectivity in adults with MS. The trial combines a gait-focused intervention with basic physical training to address sensorimotor and cognitive deficits. Researchers will assess behavioral performance and neural characteristics to understand potential neuroplastic changes. Preliminary data from related work informs the rationale, though this will be one of the first trials to test this approach in pwMS. Enrollment is limited to adults with MS who can attend to a screen and follow instructions in English.

Why it matters

Potential benefit: If successful, participants may experience improved gait adaptation, mobility, and possibly cognitive function related to motor tasks.

How similar studies have gone: Previous rehabilitation studies in MS show promise for gait and cognitive improvements, but this exact gait adaptation training approach in pwMS is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 80 yrs Clinically definite MS diagnosis Ability to attend to computer screen and follow instructions in English which will be assessed by MiniMental test requiring a participant to score \>24 (out of 30 max score) Right-handed as determined by research diagnostic criteria of the Edinburgh Handedness Inventory (Oldfield 1971) Self report of normal or corrected-to-normal vision

Exclusion Criteria Psychiatric disorders, only those requiring treatment because the medications may affect brain activation Neurological disorder that may affect cognition, balance, and/or physical wellness such as brain injury, or stroke.

Orthopedic injuries or neuromuscular disorder that may affect balance or mobility Engagement in other cognitive or physical training program while enrolled in this study Ongoing relapse (new or returning neurological symptoms) or steroid treatment during the 30 days preceding enrollment

Where it's running

  • Stanley Bergen Building
    Newark, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.